Tenax Therapeutics, Inc. (TENX): Price and Financial Metrics
TENX Price/Volume Stats
| Current price | $5.51 | 52-week high | $27.33 |
| Prev. close | $5.61 | 52-week low | $2.77 |
| Day low | $5.51 | Volume | 3,496 |
| Day high | $5.67 | Avg. volume | 242,281 |
| 50-day MA | $5.00 | Dividend yield | N/A |
| 200-day MA | $3.95 | Market Cap | 18.78M |
TENX Stock Price Chart Interactive Chart >
Tenax Therapeutics, Inc. (TENX) Company Bio
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. The company was founded in 1967 and is based in Morrisville, North Carolina.
TENX Price Returns
| 1-mo | 11.99% |
| 3-mo | 61.58% |
| 6-mo | 76.04% |
| 1-year | -77.71% |
| 3-year | N/A |
| 5-year | -99.71% |
| YTD | -74.92% |
| 2023 | -87.68% |
| 2022 | -89.29% |
| 2021 | -44.09% |
| 2020 | 31.91% |
| 2019 | 16.53% |
Loading social stream, please wait...